National Comprehensive Cancer Network



About NCCN

Acute Myeloid Leukemia Panel - Disclosures as of 3/5/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Camille N. Abboud, MD

None

ARIAD Pharmaceuticals, Inc.;
Teva

None

None

None

Jessica Altman, MD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genoptix

None

None

None

Frederick R. Appelbaum, MD

None

None

None

None

None

Daniel A. Arber, MD

None

US Diagnostic Standards

None

None

None

Eyal Attar, MD

Cincinnati Children`s Hospital;
Massachusetts General Hospital

Celgene Corporation;
Jannsen Pharmaceutica Products, LP

Celgene Corporation;
Advanced Medical;
Wallachbeth

ARIAD Pharmaceuticals, Inc.

None

Uma Borate, MD

None

None

None

None

None

Steven E. Coutre, MD

None

Celgene Corporation

None

None

None

Lloyd E. Damon, MD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Jeffrey Lancet, MD

None

Celgene Corporation;
Spectrum Pharmaceuticals

None

None

None

Lori J. Maness, MD

None

None

None

None

None

Guido Marcucci, MD

None

None

None

None

None

Michael G. Martin, MD

None

None

None

None

None

Mary Ellen Martin, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

Margaret R. O'Donnell, MD

National Cancer Institute

None

None

None

None

Daniel A. Pollyea, MD, MS

None

Celgene Corporation;
Agios

None

None

None

Farhad Ravandi, MD

Bayer HealthCare;
Celgene Corporation;
Celgene Corporation;
Merck & Co., Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.;
Sunesis Pharmaceuticals, Inc.

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

Amgen Inc.;
Sunesis Pharmaceuticals, Inc.

None

None

Paul J. Shami, MD

None

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

B. Douglas Smith, MD

None

ARIAD Pharmaceuticals, Inc.;
Clavis;
TEVA

None

None

None

Courtney Smith, PhD

None

None

None

Johnson & Johnson;
OPKO

Ethos Health Communications

Richard M. Stone, MD

Celgene Corporation;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.;
Agios;
Seattle Genetics

None

None

None

Stephen A. Strickland, MD, MSCI

None

Boehringer Ingelheim GmbH;
Sunesis Pharmaceuticals, Inc.

None

None

None

Martin S. Tallman, MD

None

Boehringer Ingelheim GmbH;
Agios Pharmaceuticals;
Seattle Genetics

None

None

None

Sarika Trikha, PharmD

None

None

None

None

None

Eunice S. Wang, MD

None

None

Incyte

None

None

Matthew Wieduwilt, MD, PhD

Celgene Corporation;
Pfizer Inc.;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

None